LivaNova Revenue and Competitors
Estimated Revenue & Valuation
- LivaNova's estimated annual revenue is currently $1B per year.
- LivaNova's estimated revenue per employee is $267,602
- LivaNova's total funding is $17.6M.
- LivaNova's current valuation is $4.5B. (January 2022)
Employee Data
- LivaNova has 3849 Employees.
- LivaNova grew their employee count by 4% last year.
LivaNova's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Staff | Reveal Email/Phone |
2 | Global procurement Vice president | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | VP, North America Sales Epilepsy | Reveal Email/Phone |
5 | VP, Emerging Therapies | Reveal Email/Phone |
6 | VP Program Management Office | Reveal Email/Phone |
7 | VP Commercial Operations | Reveal Email/Phone |
8 | VP, Global Sales and Marketing | Reveal Email/Phone |
9 | VP (General Manager Level) Sleep Apnea and Epilepsy | Reveal Email/Phone |
10 | Head LATAM Business | Reveal Email/Phone |
LivaNova Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is LivaNova?
LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol ᅢᄁ¬ツᆲᅤモLIVN.ᅢᄁ¬ツᆲᅡン LivaNova is a market leader with a workforce of more than 3,500 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. LivaNova operates as two businesses: ᅢᄁ¬ツᆲᅡᄁ Cardiac Surgery: We are a global leader in cardiac surgery based on many factors, including our established leadership position in heart-lung machines and recognition as the worldᅢᄁ¬ツᆲ¬トᄁs #1 cardiopulmonary bypass company. Our advanced solutions have made significant contributions to open-heart surgery outcomes for many patients. Notably, we offer the only sutureless valve for aortic surgery. We also offer Advanced Temporary Cardiopulmonary Support Systems, including ExtraCorporeal Life Support and Percutaneous Mechanical Circulatory Support. ᅢᄁ¬ツᆲᅡᄁ Neuromodulation: As pioneers of the VNS (Vagus Nerve Stimulation) Therapyᅢツᅡᆴ System, we continue to advance medical device solutions for people affected by Drug-Resistant Epilepsy, Treatment-Resistant Depression and Heart Failure. We also treat obstructive sleep apnea (OSA) with an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, opening the airway while a patient is sleeping. At LivaNova, we serve health and improve lives. Day by day. Life by life.
keywords:N/A$17.6M
Total Funding
3849
Number of Employees
$1B
Revenue (est)
4%
Employee Growth %
$4.5B
Valuation
N/A
Accelerator
LivaNova News
Analysts expect LivaNova to post earnings of $0.52 per share for the quarter. LivaNova has set its FY22 guidance at $2.50-2.80 EPS and its FY...
LivaNova Plc, GlaxoSmithKline Plc, Novartis AG, Medtronic, Pfizer Inc., Abbott Laboratories. Market factors could use prospect information to...
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $969.9M | 3849 | 3% | N/A |
#2 | $2510M | 3850 | 3% | N/A |
#3 | $1457.6M | 3856 | 8% | N/A |
#4 | $1565.9M | 3857 | 1% | N/A |
#5 | $1383.6M | 3891 | 7% | N/A |